Zhenlin Yang

1.3k total citations
37 papers, 633 citations indexed

About

Zhenlin Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Zhenlin Yang has authored 37 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Zhenlin Yang's work include Cancer Immunotherapy and Biomarkers (15 papers), Lung Cancer Treatments and Mutations (13 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Zhenlin Yang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Lung Cancer Treatments and Mutations (13 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Zhenlin Yang collaborates with scholars based in China and United States. Zhenlin Yang's co-authors include Jie He, Wei Guo, Renda Li, Jiachen Xu, Yibo Gao, Fengwei Tan, Qi Xue, Fei Shao, Shugeng Gao and Qilin Huai and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Nature Chemistry.

In The Last Decade

Zhenlin Yang

34 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenlin Yang China 16 314 252 235 152 128 37 633
Hongbing Shi China 12 321 1.0× 167 0.7× 159 0.7× 89 0.6× 204 1.6× 25 626
Rishab Ramapriyan United States 9 320 1.0× 177 0.7× 215 0.9× 184 1.2× 158 1.2× 18 598
Renda Li China 15 257 0.8× 232 0.9× 391 1.7× 264 1.7× 89 0.7× 26 681
Keren Jia China 11 299 1.0× 193 0.8× 124 0.5× 99 0.7× 134 1.0× 20 523
Kimberley M. Heinhuis Netherlands 10 508 1.6× 197 0.8× 202 0.9× 87 0.6× 261 2.0× 15 797
Peipei Zhang China 10 174 0.6× 209 0.8× 163 0.7× 92 0.6× 166 1.3× 27 495
Zhilan Xiao China 13 326 1.0× 196 0.8× 177 0.8× 114 0.8× 268 2.1× 21 651
Kewen He China 14 516 1.6× 296 1.2× 175 0.7× 126 0.8× 224 1.8× 34 838
Takayuki Ninomiya Japan 8 272 0.9× 153 0.6× 165 0.7× 114 0.8× 147 1.1× 17 531

Countries citing papers authored by Zhenlin Yang

Since Specialization
Citations

This map shows the geographic impact of Zhenlin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenlin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenlin Yang more than expected).

Fields of papers citing papers by Zhenlin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenlin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenlin Yang. The network helps show where Zhenlin Yang may publish in the future.

Co-authorship network of co-authors of Zhenlin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenlin Yang. A scholar is included among the top collaborators of Zhenlin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenlin Yang. Zhenlin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Qing, Yue Peng, Zhenlin Yang, et al.. (2025). Pulmonary macrophage-targeted RNAi and mRNA co-delivery via SORT lipid nanoparticles enhances immunotherapy in lung cancer. Journal of Controlled Release. 390. 114519–114519.
2.
Chen, Xiaowei, Bo Zhang, Jianfei Shen, et al.. (2025). The Survival for Pneumonectomy After Neoadjuvant Therapy in Non-small Cell Lung Cancer: A Retrospective Study from the National Cancer Center in China. Annals of Surgical Oncology. 33(2). 905–917.
3.
Yang, Zhenlin, Bolun Zhou, Wei Guo, et al.. (2024). Genomic characteristics and immune landscape of super multiple primary lung cancer. EBioMedicine. 101. 105019–105019. 6 indexed citations
4.
Bai, Guangyu, Peng Yue, Ying Ji, et al.. (2024). Surgery challenges and postoperative complications of lung cancer after neoadjuvant immunotherapy. Thoracic Cancer. 15(14). 1138–1148. 3 indexed citations
5.
Zhang, Hao, Haojie Zhang, Xiaohong Wang, et al.. (2024). The role of epigenetic methylations in thyroid Cancer. World Journal of Surgical Oncology. 22(1). 281–281. 4 indexed citations
6.
Yang, Zhenlin, He Tian, Bozhao Li, et al.. (2024). Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma. Nature Communications. 15(1). 9097–9097. 25 indexed citations
7.
Xie, Xiao, Zhaoming Chen, Mingdong Yang, et al.. (2024). Spatiotemporal protein interactome profiling through condensation-enhanced photocrosslinking. Nature Chemistry. 17(1). 111–123. 5 indexed citations
8.
Li, Runze, Zhifei Li, Zhenlin Yang, et al.. (2024). The presence of micropapillary and/or solid subtypes is an independent prognostic factor for patients undergoing curative resection for stage I lung adenocarcinoma with ground-glass opacity. Translational Lung Cancer Research. 13(2). 256–268. 4 indexed citations
9.
Chen, Xiaowei, Guangyu Bai, Ruochuan Zang, et al.. (2023). Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer. Translational Oncology. 35. 101725–101725. 6 indexed citations
10.
Wang, Yalong, Zhenlin Yang, Ping Chen, et al.. (2023). Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis. Cancer Gene Therapy. 2 indexed citations
11.
Bai, Guangyu, Zhenlin Yang, Ping Chen, et al.. (2023). Multiple primary lung cancer: Updates of clinical management and genomic features. Frontiers in Oncology. 13. 1034752–1034752. 11 indexed citations
12.
Guo, Wei, Bolun Zhou, Zhenlin Yang, et al.. (2022). Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma. EBioMedicine. 84. 104281–104281. 44 indexed citations
13.
Chu, Xiao, He Tian, Yujia Zheng, et al.. (2022). Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy. Frontiers in Cell and Developmental Biology. 10. 1013885–1013885. 24 indexed citations
14.
Yang, Zhenlin, Yue Peng, Jiachen Xu, et al.. (2022). PVR/TIGIT and PD-L1/PD-1 expression predicts survival and enlightens combined immunotherapy in lung squamous cell carcinoma. Translational Oncology. 24. 101501–101501. 16 indexed citations
15.
Sun, Sijin, Kailun Fei, Guochao Zhang, et al.. (2021). Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas. Frontiers in Genetics. 11. 617174–617174. 17 indexed citations
16.
Guo, Wei, Fengwei Tan, Qilin Huai, et al.. (2021). Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Frontiers in Immunology. 12. 669750–669750. 70 indexed citations
17.
Li, Renda, Zhenlin Yang, Hong Sheng Cheng, et al.. (2021). Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes. Nature Communications. 12(1). 3785–3785. 29 indexed citations
18.
Tian, Yanhua, Jiachen Xu, Qian Chu, et al.. (2020). A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients. BMC Medicine. 18(1). 232–232. 22 indexed citations
19.
Yang, Zhenlin, Jiachen Xu, Lin Li, et al.. (2020). Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma. Nature Communications. 11(1). 4878–4878. 42 indexed citations
20.
Wan, Rui, Zhijie Wang, J. Jack Lee, et al.. (2017). Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(9). 1376–1387. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongbing Shi Breakdown of academic impact, for papers by Rishab Ramapriyan Breakdown of academic impact, for papers by Renda Li Breakdown of academic impact, for papers by Keren Jia Breakdown of academic impact, for papers by Kimberley M. Heinhuis Breakdown of academic impact, for papers by Peipei Zhang Breakdown of academic impact, for papers by Zhilan Xiao Breakdown of academic impact, for papers by Kewen He Breakdown of academic impact, for papers by Takayuki Ninomiya
Rankless by CCL
2026